FDA recall Z-1747-2025

Foundation Medicine, Inc. · Class II · device

Product

FoundationOne Companion Diagnostic (F1CDx)

Reason for recall

Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.

Distribution

Worldwide - US Nationwide distribution in the states of GA, NY and the country of Russia.

Key facts

Status
Ongoing
Initiation date
2025-04-09
Report date
2025-05-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cambridge, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1747-2025